Home Cart Sign in  
Chemical Structure| 15291-76-6 Chemical Structure| 15291-76-6

Structure of Ginkgolide C
CAS No.: 15291-76-6

Chemical Structure| 15291-76-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ginkgolide C can enhance the cardiac function of rats in the body, is a flavone isolated from Ginkgo biloba leaves.

Synonyms: BN-52022; 1,7-dihydroxy Ginkgolide A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ginkgolide C

CAS No. :15291-76-6
Formula : C20H24O11
M.W : 440.40
SMILES Code : C[C@]([C@@]1(O)[C@](O2)([H])[C@](O)([H])[C@@]3([C@]14C5=O)[C@@](O5)([H])[C@@](O)([H])[C@@]([C@]([C@@](O4)([H])O6)3[C@](O)([H])C6=O)([H])C(C)(C)C)([H])C2=O
Synonyms :
BN-52022; 1,7-dihydroxy Ginkgolide A
MDL No. :MFCD06642603

Safety of Ginkgolide C

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Ginkgolide C

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Hep3B cells 30 μM 30 minutes GGC inhibited HGF-induced c-Met phosphorylation. Int J Mol Sci. 2020 Nov 5;21(21):8303
HCCLM3 cells 30 μM 30 minutes GGC inhibited HGF-induced c-Met phosphorylation. Int J Mol Sci. 2020 Nov 5;21(21):8303
alveolar epithelial cells 1 µM, 10 µM, 100 µM 24 hours To investigate the protective effects of Ginkgolide C on LPS-induced alveolar epithelial cell injury and the underlying mechanisms. Results showed that Ginkgolide C significantly reduced cell injury, inhibited CD40/NF-κB signaling pathway activation, and decreased inflammatory cytokine levels. Int J Mol Med. 2021 Apr;47(4):62
HepG2 cells 0, 5, 15, 30 μM 48 hours To evaluate the anti-neoplastic effect of GGC against HCC cells, it was found that GGC inhibited HGF-induced c-Met and its downstream oncogenic pathways (PI3K/Akt/mTOR and MEK/ERK) phosphorylation, and suppressed the expression of various tumorigenic proteins. Int J Mol Sci. 2020 Nov 5;21(21):8303
rat chondrocytes 7.5, 15, 30 μM 24 hours To evaluate the protective effect of Ginkgolide C on H2O2-induced chondrocyte injury. The results showed that Ginkgolide C could inhibit H2O2-induced chondrocyte apoptosis and extracellular matrix degradation, and exert anti-inflammatory and antioxidant effects by activating the Nrf2/HO-1 pathway and inhibiting the NF-κB pathway. Front Pharmacol. 2022 Oct 28;13:1027553
neonatal rat ventricular myocytes 1, 10, 100 μM 24 hours To evaluate the protective effect of Ginkgolide C against hypoxia/reoxygenation-induced inflammatory injury in ventricular myocytes. Results showed that Ginkgolide C significantly improved cell viability, suppressed the overproduction of inflammatory cytokines (TNF-α, IL-1β, IL-6), and downregulated the expression of inflammatory proteins (ICAM-1, VCAM-1, iNOS). Front Pharmacol. 2018 Feb 21;9:109
HepG2 cells 3–100 μM 24 hours To evaluate the effect of ginkgolide C on oleic acid-induced lipid accumulation in HepG2 cells. Results showed that ginkgolide C significantly reduced excessive lipid accumulation in HepG2 cells. Saudi Pharm J. 2018 Dec;26(8):1178-1184

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice LPS-induced acute lung injury model Intraperitoneal injection 12 mg/kg, 24 mg/kg, 48 mg/kg Once daily for 7 days To evaluate the protective effects of Ginkgolide C on LPS-induced acute lung injury. Results showed that Ginkgolide C significantly improved lung histopathological changes, reduced neutrophil infiltration, and decreased lung injury scores and inflammatory cytokine levels. Int J Mol Med. 2021 Apr;47(4):62
Sprague-Dawley rats Post-traumatic osteoarthritis (PTOA) model induced by anterior cruciate ligament transection (ACLT) Gavage 5 mg/kg and 10 mg/kg Once daily for 6 weeks To evaluate the ameliorating effect of Ginkgolide C on joint pain and cartilage degeneration in ACLT-induced PTOA rats. The results showed that Ginkgolide C could reduce joint swelling, decrease mechanical sensitivity and cold hypersensitivity, inhibit cartilage destruction and abnormal bone remodeling, and exert protective effects by regulating the Nrf2/HO-1 and NF-κB pathways. Front Pharmacol. 2022 Oct 28;13:1027553
Male Sprague-Dawley rats Myocardial ischemia/reperfusion injury model Intraperitoneal injection 8, 16, 32 mg/kg Once daily for 7 days To evaluate the protective effect of Ginkgolide C against myocardial ischemia/reperfusion injury. Results showed that Ginkgolide C significantly reduced infarct size, improved myocardial ultrastructure, inhibited neutrophil infiltration, and decreased the levels of inflammatory cytokines (TNF-α, IL-1β, IL-6). Front Pharmacol. 2018 Feb 21;9:109
Rats Myocardial ischemia/reperfusion injury model 8 mg/kg, 16 mg/kg, 32 mg/kg To evaluate the protective effect of Ginkgolide C on myocardial ischemia/reperfusion injury, results showed that Ginkgolide C significantly reduced infarct size Front Pharmacol. 2025 Jan 6;15:1492520

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.27mL

0.45mL

0.23mL

11.35mL

2.27mL

1.14mL

22.71mL

4.54mL

2.27mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories